<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">chemicallytech</journal-id><journal-title-group><journal-title xml:lang="en">Fine Chemical Technologies</journal-title><trans-title-group xml:lang="ru"><trans-title>Тонкие химические технологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-6593</issn><issn pub-type="epub">2686-7575</issn><publisher><publisher-name>MIREA – Russian Technological University (RTU MIREA).</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">chemicallytech-531</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CHEMISTRY AND TECHNOLOGY OF MEDICINAL COMPOUNDS AND BIOLOGICALLY ACTIVE SUBSTANCES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ХИМИЯ И ТЕХНОЛОГИЯ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ И БИОЛОГИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ</subject></subj-group></article-categories><title-group><article-title>PRODUCTION AND INVESTIGATION OF PROPERTIES OF LIPOSOMAL LEVOFLOXACIN</article-title><trans-title-group xml:lang="ru"><trans-title>Создание и изучение свойств липосомальной формы левофлоксацина</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сорокоумова</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Sorokoumova</surname><given-names>G. М.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра Биотехнологии и бионанотехнологии, доцент</p></bio><email xlink:type="simple">galinams@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ясин</surname><given-names>Я. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Yasin</surname><given-names>Ya. O.H.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра Биотехнологии и бионанотехнологии, студент</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Микулович</surname><given-names>Ю. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikulovich</surname><given-names>Ju. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра Биотехнологии и бионанотехнологии, ведущий инженер</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>Т. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>T. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>старший научный сотрудник</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреевская</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreevskaya</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>старший научный сотрудник</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селищева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Selischeva</surname><given-names>А. А</given-names></name></name-alternatives><bio xml:lang="ru"><p>Биологический факультет, ведущий научный сотрудник</p></bio><bio xml:lang="en"><p>Biological Faculty</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черноусова</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernousova</surname><given-names>L. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий отделом</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Швец</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shvets</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра Биотехнологии и бионанотехнологии, заведующий кафедрой</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>МИТХТ им. М.В. Ломоносова, 119571, Москва, пр-т Вернадского, д. 86</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.V. Lomonosov Moscow State University of Fine Chemical Technologies, 86, Vernadskogo pr., Moscow 119571</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Центральный научно-исследовательский институт туберкулеза РАМН, Москва, 107564</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, Moscow, 107564</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>МГУ им. М.В. Ломоносова, Москва, 119991</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.V. Lomonosov Moscow State University, Moscow, 119991</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2013</year></pub-date><volume>8</volume><issue>5</issue><fpage>72</fpage><lpage>76</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Sorokoumova G.М., Yasin Y.O., Mikulovich J.L., Smirnova T.G., Andreevskaya S.N., Selischeva А.А., Chernousova L.N., Shvets V.I., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Сорокоумова Г.М., Ясин Я.О., Микулович Ю.Л., Смирнова Т.Г., Андреевская С.Н., Селищева А.А., Черноусова Л.Н., Швец В.И.</copyright-holder><copyright-holder xml:lang="en">Sorokoumova G.М., Yasin Y.O., Mikulovich J.L., Smirnova T.G., Andreevskaya S.N., Selischeva А.А., Chernousova L.N., Shvets V.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.finechem-mirea.ru/jour/article/view/531">https://www.finechem-mirea.ru/jour/article/view/531</self-uri><abstract><p>Liposomal levofloxacin was prepared with the extrusion technique. Levofloxacin is a fluoroquinolone used for resistant tuberculosis treatment. Traditional lipids such as phosphatidylcholine (PC), as well as a mixture of PC and cholesterol (Chol) were used for liposome preparation. Antibiotic encapsulation into the liposomes was carried out with the passive and active loading methods. The active method of levofloxacin loading into liposomes was conducted with ammonium sulphate gradient. Levofloxacin encapsulation efficiency into liposomes containing PC/Chol (4:1, w/w) was found to be as high as 90% when active the loading method was used, while levofloxacin encapsulation efficiency was as low as 20% when the passive loading method was used. Levofloxacin releasing kinetics with Franz diffusion cell was investigated. Levofloxacin was shown to release gradually from liposomes containing PC and Chol to 18% for 21 h, while levofloxacin released completely for 3 h from antibiotic solution. The prepared liposomal levofloxacin was used to test its activity on extensively drug resistant strain Mycobacterium tuberculosis СN-37 growth with automatized system BACTEC MGIT 960. Mycobacterium tuberculosis СN-37 was resistant to rifampicin, isoniaside, streptomicin, ethambutol, pyrazinamide, ofloxacin, amikacin, capreomicin. Mycobacteria growth monitoring with automatized system BACTEC MGIT 960 was based on fluorescence measurement of fluorophore located at the bottom of Mycobacteria Growth Indicator Tube (MGIT). This fluorophore is «neutralized» by high oxygen concentrations. The living bacterial cells take in oxygen, which results in fluorescent increase. The liposomal levofloxacin as well as levofloxacin solution at 1 and 2 mkg/mL were found to delay mycobacteria growth by 1-2 days while both levofloxacin forms at 4 mkg/mL inhibited mycobacteria growth completely. It means that the liposomal levofloxacin is active as an antibiotic solution against mycobacteria. Summing up, it is the active loading method that can be rationally used for the liposomal levofloxacin preparing with maximal encapsulation efficiency. The prepared liposomes loaded with levofloxacin allow the antibiotic to release gradually. So, the antibiotic is active for a long time. It is important for increase of the antibiotic activity within human organism.</p></abstract><trans-abstract xml:lang="ru"><p>Получена липосомальная форма левофлоксацина - антибиотика фторхинолонового ряда, применяемого при лечении резистентных форм туберкулеза. Используемый в работе метод активной загрузки позволил достичь 90% эффективности включения этого препарата. Для получения липосом были использованы традиционные липиды - фосфатидилхолин и холестерин. Исследование действия полученного препарата на рост in vitro резистентного штамма Mycobacteriumtuberculosis СN-37, обладающего широкой лекарственной устойчивостью, показало, что липосомальная форма левофлоксацина обладает таким же бактерицидным действием, что и раствор левофлоксацина, но при этом высвобождение антибиотика из липосом происходит постепенно.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>левофлоксацин</kwd><kwd>липосомальная форма</kwd><kwd>метод активной загрузки</kwd><kwd>эффективность включения антибиотика</kwd><kwd>микобактерии туберкулеза с широкой лекарственной устойчивостью</kwd></kwd-group><kwd-group xml:lang="en"><kwd>levofloxacin</kwd><kwd>liposomal form</kwd><kwd>active encapsulation approach</kwd><kwd>encapsulation efficiency</kwd><kwd>mycobacteria&#13;
tuberculosis with extensively drug resistant.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шмелев Е.И., Чуканов В.И. Применение фторхинолонов при туберкулезе // Пульмонология и фтизиатрия. 2000. Т. 2. № 10. С. 429-431.</mixed-citation><mixed-citation xml:lang="en">Шмелев Е.И., Чуканов В.И. Применение фторхинолонов при туберкулезе // Пульмонология и фтизиатрия. 2000. Т. 2. № 10. С. 429-431.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Никитин А.В., Литовченко К.В. Побочное действие фторхинолонов. Безопасность и пере-носимость левофлоксацина при клиническом применении // Антибиотики и химиотерапия. 2002. Т. 47. № 4. С. 20-23.</mixed-citation><mixed-citation xml:lang="en">Никитин А.В., Литовченко К.В. Побочное действие фторхинолонов. Безопасность и пере-носимость левофлоксацина при клиническом применении // Антибиотики и химиотерапия. 2002. Т. 47. № 4. С. 20-23.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">/Bermudez L.E. Use of liposome preparation to treat mycobacterial infections // Immunobiology. 1994. V. 191. P. 578-583.</mixed-citation><mixed-citation xml:lang="en">/Bermudez L.E. Use of liposome preparation to treat mycobacterial infections // Immunobiology. 1994. V. 191. P. 578-583.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Furneri P.M., Fresta M., Puglisi G., Tempera. Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria // Antimicrob. Agents Chemother. 2000. V. 44. № 9. P. 2458-2464.</mixed-citation><mixed-citation xml:lang="en">Furneri P.M., Fresta M., Puglisi G., Tempera. Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria // Antimicrob. Agents Chemother. 2000. V. 44. № 9. P. 2458-2464.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cyprian O.O., Nightingale C.H., Nicolau D.P., Quintiliani R. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages // Antimicrob. Agents Chemother. 1994. V. 38. № 3. P. 523-527.</mixed-citation><mixed-citation xml:lang="en">Cyprian O.O., Nightingale C.H., Nicolau D.P., Quintiliani R. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages // Antimicrob. Agents Chemother. 1994. V. 38. № 3. P. 523-527.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fresta M., Sprado A., Cerniglia G., Ropero I.M., Puglisi G., Furneri P.M. Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts // Antimicrob. Agents Chemother. 1995. V. 39. № 6. P. 1372-1375.</mixed-citation><mixed-citation xml:lang="en">Fresta M., Sprado A., Cerniglia G., Ropero I.M., Puglisi G., Furneri P.M. Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts // Antimicrob. Agents Chemother. 1995. V. 39. № 6. P. 1372-1375.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Титов И.В., Дорофеев В.Л., Арзамасцев А.П. Использование метода УФ-спектрометрии для установления подлинности лекарственных средств группы фторхинолонов // Вестник ВГУ. 2004. № 2. C. 264-269.</mixed-citation><mixed-citation xml:lang="en">Титов И.В., Дорофеев В.Л., Арзамасцев А.П. Использование метода УФ-спектрометрии для установления подлинности лекарственных средств группы фторхинолонов // Вестник ВГУ. 2004. № 2. C. 264-269.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang X., Sun P., Ru Bi, Wang J., Zhang Na, Huang G. Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation // J. Drug Targeting. 2009. V. 17. № 5. P. 399-407.</mixed-citation><mixed-citation xml:lang="en">Zhang X., Sun P., Ru Bi, Wang J., Zhang Na, Huang G. Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation // J. Drug Targeting. 2009. V. 17. № 5. P. 399-407.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Wang J., Miao L., Zhang X., Huang G. Prolonged systemic delivery of antibacterial agent levofloxacin using liposomes // Asian J. Pharm. Sci. 2011. V. 6. № 6. P. 259-266.</mixed-citation><mixed-citation xml:lang="en">Liu X., Wang J., Miao L., Zhang X., Huang G. Prolonged systemic delivery of antibacterial agent levofloxacin using liposomes // Asian J. Pharm. Sci. 2011. V. 6. № 6. P. 259-266.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
